TradingView’s new script rules: what traders should check

Last updated: October 14, 2026 Disclosure: TakeProfit is one of the platforms mentioned. Claims about other platforms are based on their public pages and public user discussions, cited in the text. What changed We checked TradingView’s Terms of…


Last updated: October 14, 2026
Disclosure: TakeProfit is one of the platforms mentioned. Claims about other platforms are based on their public pages and public user discussions, cited in the text.

What changed

We checked TradingView’s Terms of Use on October 14, 2026. The main change traders are talking about is not a new chart feature, but a tighter rule around invite-only scripts.

TradingView’s current Terms say: “Invite-only scripts published on TradingView may be used for non-commercial purposes only. Commercial use of any invite-only script is prohibited.” The same section defines commercial use broadly, including when a fee, subscription, donation, or other payment is charged or requested for access to the script, or when the script is used to advertise a paid product, paid community, paid course, or referral program.

The Terms also say that if TradingView determines a user has made commercial use of an invite-only script, or otherwise violated this section after 1 November 2026, it may block or terminate access to TradingView and invite-only scripts, remove scripts and profile content, and take other account actions.

TradingView’s Terms also now say: “Scripts available for Commercial Use are only permitted to be distributed via the Marketplace. You can apply through the Creator Program.” TradingView’s blog post on 2026-09-30 said non-commercial use of invite-only scripts continues without changes, but selling access or bundling it into another paid product will no longer be permitted from 2026-11-01 unless creators contact TradingView before then.

That is the practical shift: invite-only scripts are still allowed for non-commercial use, but paid distribution is being pushed into the Marketplace.

What traders are saying

On Reddit, the discussion is broader than scripts alone. Several traders on r/TradingView say the current wave is also about pricing and extra charges, not just policy language.

  • One user on r/TradingView pushed back on complaints about price increases, saying TradingView has costs beyond charts and data, including infrastructure, support, and exchange licensing.
  • Another user on r/TradingView wrote, “Thats an additional monthly fee now. /s ( I hope /s)”, reflecting the concern that more charges are being layered on.
  • A different user on r/TradingView said the platform price “hasn’t altered” in the way some people thought, and pointed to app-store fees as part of the confusion.
  • Another trader on r/TradingView focused on the substance of automation and said the real test is whether a bot or script has a verified record and clear rules, not just whether it is sold.

Taken together, the discussion suggests two separate worries: what TradingView now allows for commercial scripts, and whether the overall cost structure is becoming less predictable.

What it means for you

If you use invite-only scripts, the first thing to check is whether any part of your workflow is commercial under TradingView’s definition. That includes direct payment, donations, subscriptions, paid communities, paid courses, referral links, or using the script page or profile to promote a paid product.

If you sell access to a script, or bundle it into another paid service, the current Terms point you toward the Marketplace. If you are a buyer, check whether your access was purchased before the cutoff and whether the vendor has said anything about Marketplace migration.

If you only use invite-only scripts privately, TradingView says non-commercial use continues without changes. Still, it is worth reviewing:
– whether your script page or profile contains paid promotions,
– whether any access is tied to a subscription or donation,
– whether your vendor has moved distribution to the Marketplace,
– and whether your current setup depends on invite-only access that could be blocked after 2026-11-01.

For traders who mainly want browser-based charting and cloud alerts without having to track shifting script rules, TakeProfit is one option to compare. It offers a free Freeroll tier, an All-In plan at $20/month or $120/year, a 30-day free trial with no card, Python-based scripting via Indie, and alerts that typically run in about 300 ms end to end.

Alternatives worth a look

  • TakeProfit — for traders who want browser-based charting, cloud alerts, and Python-style scripting in one stack.
  • TrendSpider — for traders who want automated chart analysis and a more guided technical workflow.
  • NinjaTrader — for active futures traders who want a desktop-first trading and analysis platform.
  • thinkorswim — for traders who want a broker-linked platform with deep charting and options tools.
  • Sierra Chart — for traders who want a highly configurable platform with a strong reputation among advanced users.
  • GoCharting — for traders who want browser-based charting with a lighter setup.

FAQ

  • Does TradingView still allow invite-only scripts?
  • Yes, but current Terms say they are for non-commercial use only.

  • What happens to paid script distribution?

  • TradingView says scripts available for commercial use are only permitted through the Marketplace, and the Terms say enforcement can apply after 1 November 2026.

  • What should I check in my own workflow?

  • Review whether your script, profile, or page is tied to payment, donations, referrals, paid communities, or other commercial use.

This is not investment advice.

Keep reading